&#xa0;
[normal]&#xa0;
[normal]Written evi[bold]dence from[bold] Roche Diagnostics [bold]UK (PEX 0011)[bold]&#xa0;[bold]Summary[bold]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;[bold]Diabetes[bold]&#xa0;[bold]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]Self-monitoring of blood glucose (SMBG) [bold]&#xa0;[bold]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]Diabetes [bold]self-monitoring[bold] restriction[bold]s[bold]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]Access to innovative blood glucose testing[bold]&#xa0;
[normal]&#xa0;[bold]Conclusion[bold]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]About Roche Diagnostics UK [bold]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]November 2013
[normal]&#xa0;
[normal] State of the Nation 2012: England, Diabetes UK
[normal] 
[normal]Self-monitoring of 
[normal]blood glucose levels f
[normal]or adults with Type 2 diabetes, April 2013, Diabetes UK
[normal] 
[normal]Cardiovascular - type 2 diabetes. Data focused commentary: Type 2 diabetes: Self-monitoring blood glucose. Nat
[normal]ional Prescribing Centre (2012)
[normal] 
[normal]https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/156336/Safe-care-of-people-with-type-1-diabetes.pdf.pdf
[normal] (accessed 01
[normal] November
[normal] 2013)
[normal] 
[normal]ACCESS TO TEST STRIPS: A POSTCODE LOTTERY? 
[normal]Self-monitoring
[normal] of blood glucose by people with Type 1 and Type 2 diabetes, August 2013, Diabetes UK
[normal]